echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Synthesis, Characterization, and Evaluation of Radiometal-Containing Peptide Nucleic Acids

    Synthesis, Characterization, and Evaluation of Radiometal-Containing Peptide Nucleic Acids

    • Last Update: 2020-11-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Peptide nucleic acids (PNAs) have very attractive properties for applications in nuclear medicine. Because PNAs have highselectivity for
    DNA
    /RNA recognition, resistance to nuclease/protease degradation, and high thermal and radiolytic stabilities,PNA bioconjugates could transform the areas of diagnostic and therapeutic nuclear medicine. In this book chapter, we reporton the current developments towards the preparation of radiometal-containing PNA constructs and summarize the protocols forlabeling these probes with
    99m
    Tc,
    111
    In,
    64
    Cu,
    90
    Y, and
    177
    Lu.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.